Pfizer Shares Outstanding 2006-2018 | PFE

Pfizer shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Pfizer shares outstanding for the quarter ending September 30, 2018 were 5.986B, a 0.91% decline year-over-year.
  • Pfizer 2017 shares outstanding were 6.058B, a 1.64% decline from 2016.
  • Pfizer 2016 shares outstanding were 6.159B, a 1.57% decline from 2015.
  • Pfizer 2015 shares outstanding were 6.257B, a 2.6% decline from 2014.
Pfizer Annual Shares Outstanding
(Millions of Shares)
2017 6,058
2016 6,159
2015 6,257
2014 6,424
2013 6,895
2012 7,508
2011 7,870
2010 8,074
2009 7,045
2008 6,750
2007 6,939
2006 7,274
2005 7,411
Pfizer Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 5,986
Q2 2018 5,952
Q1 2018 6,057
Q4 2017 6,058
Q3 2017 6,041
Q2 2017 6,037
Q1 2017 6,092
Q4 2016 6,159
Q3 2016 6,150
Q2 2016 6,149
Q1 2016 6,225
Q4 2015 6,257
Q3 2015 6,243
Q2 2015 6,243
Q1 2015 6,292
Q4 2014 6,424
Q3 2014 6,403
Q2 2014 6,444
Q1 2014 6,476
Q4 2013 6,895
Q3 2013 6,656
Q2 2013 7,117
Q1 2013 7,269
Q4 2012 7,508
Q3 2012 7,508
Q2 2012 7,537
Q1 2012 7,598
Q4 2011 7,870
Q3 2011 7,810
Q2 2011 7,935
Q1 2011 8,035
Q4 2010 8,074
Q3 2010 8,057
Q2 2010 8,072
Q1 2010 8,101
Q4 2009 7,045
Q3 2009 6,762
Q2 2009 6,752
Q1 2009 6,753
Q4 2008 6,750
Q3 2008 6,736
Q2 2008 6,748
Q1 2008 6,762
Q4 2007 6,939
Q3 2007 6,894
Q2 2007 6,990
Q1 2007 7,075
Q4 2006 7,274
Q3 2006 7,251
Q2 2006 7,305
Q1 2006 7,348
Q4 2005 7,411
Q3 2005 7,382
Q2 2005 7,418
Q1 2005 7,474
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $261.450B $52.546B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.174B 18.29
Merck (MRK) United States $206.852B 17.92
Novartis AG (NVS) Switzerland $201.155B 17.24
AbbVie (ABBV) United States $130.807B 11.61
Eli Lilly (LLY) United States $120.318B 21.15
Novo Nordisk (NVO) Denmark $110.887B 18.01
Sanofi (SNY) France $109.052B 13.50
AstraZeneca (AZN) United Kingdom $96.706B 12.01
GlaxoSmithKline (GSK) United Kingdom $92.502B 12.43
Bristol-Myers Squibb (BMY) United States $86.637B 14.27